U.S. Paper and Forestry Products Stock News

NYSE:AMPX
NYSE:AMPXElectrical

Amprius Technologies (AMPX) Is Down 23.5% After Hiking 2026 Outlook And Landing Major Defense Deals

Amprius Technologies reported past first-quarter 2026 results with record revenue of US$28.54 million, shrinking net loss to US$5.05 million and turning gross margins positive compared with the prior year. The company also raised its 2026 revenue outlook to at least US$130 million and highlighted roughly US$500 million in new U.S. defense awards plus a US$21 million Chinese mobility order, reinforcing growing demand for its silicon-anode batteries. We will now examine how this upgraded...
NYSE:EME
NYSE:EMEConstruction

EMCOR’s Inter Miami Deal Adds High Profile Twist To Valuation Debate

Hill York Service, an EMCOR Group subsidiary, has been selected as the official HVAC partner for Inter Miami CF's new Nu Stadium. The agreement covers HVAC systems for the new venue and aligns EMCOR with a high profile sports facility project. This development adds a fresh angle to the EMCOR story beyond recent attention on quarterly results and guidance. For investors tracking EMCOR Group (NYSE:EME), the Hill York Service partnership with Inter Miami CF comes on top of a stock that has...
NasdaqGS:ASTE
NasdaqGS:ASTEMachinery

Astec Industries (ASTE) Is Down 18.5% After Q1 Margin Squeeze Despite Strong Sales Growth – What's Changed

In early May 2026, Astec Industries, Inc. reported first-quarter 2026 results showing net sales of US$396.3 million, up from US$329.4 million a year earlier, while GAAP net income fell to US$1.3 million and diluted earnings per share from continuing operations declined to US$0.06. Beneath the strong top-line growth, Astec’s sharp margin compression, earnings miss versus analyst expectations, and increased costs from tariffs, freight, and trade shows highlight a tension between robust demand...
NYSE:MSI
NYSE:MSICommunications

Motorola Solutions Leans Into AI Public Safety Deals And Raised Outlook

Motorola Solutions (NYSE:MSI) reports record Q1 revenue, backlog, and operating margin expansion. The company raises its full-year revenue and margin guidance on what it describes as record demand. Motorola Solutions announces acquisitions of Exacom and Hyper, plus a definitive agreement to acquire Bell Canada’s LMR networks services business. Agentic AI is being integrated into the Software segment and digital evidence management to support next-generation public safety...
NasdaqGM:BLZE
NasdaqGM:BLZEIT

Backblaze (BLZE) Valuation Check After Beat And Raise Earnings And AI Storage Optimism

Backblaze (BLZE) drew fresh attention after first quarter 2026 results, with revenue of US$38.67 million and a net loss of US$6.15 million, alongside higher full year revenue guidance. See our latest analysis for Backblaze. The beat and raise has been met with sharp buying interest, with Backblaze’s share price at US$7.50 and a 30 day share price return of 107.18%, while the 1 year total shareholder return sits at 42.86%. This suggests strong recent momentum on expectations for AI related...
NasdaqGS:SEDG
NasdaqGS:SEDGSemiconductor

A Look At SolarEdge Technologies (SEDG) Valuation After Its Recent Share Price Weakness

SolarEdge Technologies (SEDG) has drawn fresh attention after a sharp 1-day move, with the stock down about 4.9% to close at US$38.61, prompting investors to reassess recent performance trends. See our latest analysis for SolarEdge Technologies. That 4.9% one day share price drop comes after a 7 day share price return of about a 9.9% decline and a 30 day share price return of around a 12% decline, even as the year to date share price return is roughly 23% and the 1 year total shareholder...
NYSE:ORA
NYSE:ORARenewable Energy

A Look At Ormat Technologies (ORA) Valuation After Strong 1 Year Shareholder Returns

Key recent performance metrics Ormat Technologies (ORA) has drawn investor attention after a year total return of 66.17%, along with a nearly flat return over the past three months and a market value of about US$7.06b. See our latest analysis for Ormat Technologies. The recent 1-day share price return of 6.67% and 1-month share price return of 9.16% sit against a 1-year total shareholder return of 66.17%. This suggests momentum has picked up again after a softer patch. If you are comparing...
NYSE:M
NYSE:MMultiline Retail

Can Macy’s On 34th Molly Rogers Collection Clarify The Private-Label Strategy Behind (M)?

Macy’s recently announced its latest On 34th collaboration with Emmy Award–winning costume designer Molly Rogers, launching a 44-piece apparel and accessories collection now available in select stores, on Macys.com, and via the Macy’s app, with prices ranging from US$19.50 to US$139.50 and sizes from XXS to XXL. The partnership weaves Rogers’ film and television costume aesthetic into accessible retail, potentially reinforcing Macy’s push to differentiate its private-label offering through...
NasdaqGS:AMLX
NasdaqGS:AMLXPharmaceuticals

Amylyx Readies Avexitide For PBH With Pivotal Trial And Valuation Gap

Amylyx Pharmaceuticals (NasdaqGS:AMLX) is advancing avexitide through the pivotal Phase III LUCIDITY trial for post-bariatric hypoglycemia (PBH). Pivotal Phase III data from LUCIDITY are expected next quarter. The company has also started a U.S. expanded access program so certain PBH patients can receive avexitide before any potential approval. Amylyx Pharmaceuticals focuses on therapies for serious neurological and metabolic conditions, with avexitide as its lead candidate for PBH. PBH can...
NYSE:GENI
NYSE:GENIHospitality

Genius Sports (GENI) Valuation Check After Q1 2026 Guidance Lift And Legend Acquisition

Genius Sports (GENI) stock was in focus after the company paired strong Q1 2026 revenue of US$187.95 million with a wider net loss and a sizeable guidance lift following the Legend acquisition. See our latest analysis for Genius Sports. The recent guidance lift and Legend acquisition came after a tough stretch for investors, with the share price down 55.66% year to date and the 1 year total shareholder return at a 53.23% loss. At the same time, the stock has posted a 13.00% 1 month share...
NYSE:CPNG
NYSE:CPNGMultiline Retail

Coupang (CPNG) Is Down 13.8% After Cyber-Hit Loss and Bigger Buyback – Has The Bull Case Changed?

In early May 2026, Coupang reported first-quarter 2026 revenue of US$8,504 million, swinging from net income of US$107 million a year earlier to a net loss of US$266 million, while also expanding its equity buyback authorization to US$2.00 billion after repurchasing 29,216,918 shares under its existing program. The results underscored the ongoing impact of a late‑2025 cyber incident, pressuring margins through customer vouchers and underused capacity, even as Coupang recovered nearly 80% of...
NasdaqCM:TSSI
NasdaqCM:TSSIIT

How Investors Are Reacting To TSS (TSSI) Revenue Drop Amid AI Integration Push And Steady EBITDA Outlook

TSS, Inc. reported past first-quarter 2026 results with revenue of US$55.35 million and net income of US$2.28 million, down from US$98.96 million and US$2.98 million a year earlier, alongside lower earnings per share. Despite lower headline revenue, management highlighted strong AI-driven systems integration activity, maintained its full-year adjusted EBITDA outlook, and reinforced its AI infrastructure focus with senior hires in strategy and technology. We’ll now examine how this AI-fueled...
NasdaqGS:MNST
NasdaqGS:MNSTBeverage

Is It Too Late To Consider Monster Beverage (MNST) After Strong Multi Year Share Gains?

If you are wondering whether Monster Beverage is priced attractively or fully reflecting its prospects, the recent share performance gives you plenty to think about. The stock last closed at US$86.29, with returns of 11.9% over 7 days, 14.0% over 30 days, 13.3% year to date, 41.5% over 1 year, 44.9% over 3 years and 87.3% over 5 years. Recent coverage has focused on Monster Beverage's position within the broader beverages sector and how investors are weighing its growth potential against...
NYSE:CDE
NYSE:CDEMetals and Mining

A Look At Coeur Mining (CDE) Valuation As Record Q1 Results And New Capital Returns Draw Focus

Coeur Mining (CDE) is back in focus after reporting record first quarter revenue of US$856.19 million and net income of US$246.76 million, supported by newly acquired New Gold mines and fresh capital return plans. See our latest analysis for Coeur Mining. At a share price of US$18.12, Coeur Mining has seen a 3.25% year to date share price return and a very large 3 year total shareholder return, helped by the New Gold acquisition, strong Q1 results and fresh capital return plans. However, the...
NYSE:SE
NYSE:SEMultiline Retail

Evaluating Sea (NYSE:SE) After Recent Share Swings And Mixed Valuation Signals

Sea stock reaction and business mix Sea (NYSE:SE) has drawn investor attention after recent share price swings that include a month gain and a decline over the past 3 months, prompting a closer look at how its core businesses and regional exposure line up. See our latest analysis for Sea. Sea’s recent moves tell a mixed story, with a 30 day share price return of 8.95% and a 7 day gain of 4.43% coming after a 90 day share price decline of 18.33% and a 1 year total shareholder return of 39.21%...
NasdaqGM:ENPH
NasdaqGM:ENPHSemiconductor

Why Enphase Energy (ENPH) Is Up 7.6% After Securing New IQ9 Microinverter Safe Harbor Deal

In late April 2026, Enphase Energy announced a new safe harbor agreement with a U.S. solar and battery financing company that offers third-party ownership structures, expected to generate about US$52,000,000 in revenue and expand its physical work test backlog for IQ9 Microinverters to roughly US$873,700,000 through 2030. This deal not only deepens Enphase’s footprint in the third-party ownership channel but also points to multi‑year visibility for U.S.-made IQ9 Microinverter demand, with...
NasdaqGM:TRUP
NasdaqGM:TRUPInsurance

A Look At Trupanion (TRUP) Valuation After First Quarter 2026 Earnings Turn To Net Income

Trupanion (TRUP) has moved into focus after reporting first quarter 2026 results, showing net income of US$4.88 million, compared with a net loss of US$1.48 million in the same period a year earlier. See our latest analysis for Trupanion. Recent trading reflects a mixed picture, with a 2.69% 1 day share price return and 6.67% 7 day share price return contrasting with a 31.21% year to date share price decline and a 41.92% 1 year total shareholder return decline. This suggests recent momentum...
NYSE:FLR
NYSE:FLRConstruction

Is It Too Late To Consider Fluor (FLR) After Its Strong One Year Rally?

For investors wondering whether Fluor stock still offers value after a strong run, or if most of the opportunity is already priced in, this article focuses squarely on what you are paying versus what you are getting. Fluor recently closed at US$51.08, with returns of 7.0% over 30 days, 22.5% year to date and 43.4% over 1 year. This puts its longer term 3 year and 5 year returns at 93.0% and 169.8% respectively. Recent coverage has highlighted Fluor's role as a large engineering and...
NYSE:U
NYSE:USoftware

Is Unity Software (U) Now Fairly Priced After Recent Share Price Rebound?

Wondering if Unity Software at around US$26.73 is offering fair value or if the stock price is out of sync with the business? This article walks through what the numbers are saying so you can judge that for yourself. The stock has returned 1.2% over the past week and 21.4% over the last 30 days, while year to date it shows a 39.6% decline and a 29.4% return over the past year, highlighting that sentiment around risk and potential has shifted more than once. Recent headlines have focused on...
NYSE:BRBR
NYSE:BRBRPersonal Products

Is BellRing Brands (BRBR) Mispriced After Its Sharp 83% One Year Share Price Slump

If you are wondering whether BellRing Brands' current share price offers value or just more volatility, it helps to start with what the recent returns are actually telling you. The stock last closed at US$10.46, with returns of a 41.2% decline over 7 days, a 33.2% decline over 30 days, a 59.9% decline year to date and an 83.1% decline over the past year. This clearly changes how many investors think about its potential and its risks. Recent coverage has focused on how the company fits into...
NYSE:BXP
NYSE:BXPOffice REITs

BXP Headquarters Shift Highlights Tenant Strategy And Washington DC Portfolio Choices

BXP (NYSE:BXP) is relocating its regional headquarters to make room for major tenant the Washington Commanders in Foggy Bottom. The company is moving into a newly renovated downtown Washington, DC office building as part of this shift. The relocation aligns with recent leasing activity and capital deployment in the DC market. For investors watching NYSE:BXP, this move ties directly to how the company is using its portfolio to support active leasing and tenant relationships. The stock last...
NYSE:KBR
NYSE:KBRProfessional Services

A Look At KBR (KBR) Valuation After Major U.S. Contract Wins And Q1 2026 Earnings Beat

KBR (KBR) is back in focus after a run of sizeable U.S. government wins, including a $449 million Army LOGCAP V extension, a $510 million analytics contract, and fresh Air Force AFCAP V task orders. See our latest analysis for KBR. Despite a series of sizeable government contract wins and reaffirmed guidance, sentiment around KBR has softened, with a 30-day share price return of -12.05% and a 1-year total shareholder return of -38.54% pointing to fading momentum after a tougher few years. If...
NasdaqGS:MNDY
NasdaqGS:MNDYSoftware

A Look At monday.com (MNDY) Valuation After Launching Its New AI Work Platform

monday.com (MNDY) has reintroduced itself as an AI Work Platform, centering its offer on built in AI agents that automate workflows across departments and connect with tools like Anthropic’s Claude and Microsoft 365 Copilot. See our latest analysis for monday.com. The AI Work Platform launch and the upcoming earnings report have arrived after a weak stretch for the stock, with a 90 day share price return of 22.05% decline and a 1 year total shareholder return of 72.88% decline. However,...
NasdaqCM:INO
NasdaqCM:INOBiotechs

Is Inovio (INO) Turning Fresh DNA Medicine Data Into a More Coherent Investment Story?

Inovio Pharmaceuticals recently announced plans to release its Q1 2026 earnings after market close on May 13, 2026, alongside a conference call and upcoming scientific presentations on its DNA medicine pipeline for HPV-related diseases, cancer, and infectious diseases. Investor attention has intensified as Inovio’s DNA vaccine and gene transfer programs gain visibility, supported by significant institutional ownership and new clinical data disclosures on candidates such as INO-3107 and its...